Reviewed by the Help Dementia Editorial Team — our editors review every article for accuracy against guidance from the National Institute on Aging, the Alzheimer’s Association, and peer-reviewed sources.
Dementia screening sits at the center of this dementia and brain health question.
If you or a loved one has just completed a dementia screening test, you likely have questions about what the results mean and what comes next. The most important questions to ask your doctor are about the actual test results and their interpretation, whether additional testing is recommended, what the next diagnostic steps look like, how the condition might progress, and what treatment or management options are available. A dementia screening is typically just the first step in the diagnostic process—it’s a signal that warrants further investigation, not a definitive diagnosis of Alzheimer’s disease or another form of dementia.
Many people leave their doctor’s office after a screening with a folder of test scores but little understanding of what those numbers actually mean for their health. Your doctor has the expertise to translate clinical findings into practical information that affects your daily life, your family planning, and your medical decisions going forward. It’s crucial to ask clarifying questions before you leave that appointment.
Table of Contents
- What Do My Screening Results Actually Tell Us?
- What Are the Limitations of This Screening Test?
- What Additional Testing or Evaluation Do You Recommend?
- If This Is Dementia, What Type and Stage Are We Looking At?
- What Treatment Options or Interventions Are Available?
- What Should My Family Know, and What Planning Should We Start Now?
- How Often Should I Be Monitored, and What Should I Watch For?
- Conclusion
- Frequently Asked Questions
What Do My Screening Results Actually Tell Us?
After a cognitive screening—whether it’s the Montreal Cognitive Assessment (MoCA), the Mini-Cog, the MMSE, or another tool—your first question should be to ask your doctor to explain your specific score in plain language. Screening tests produce numerical results that are interpreted against established cutoff scores, but the same score can mean different things depending on your age, education level, and other health factors. For example, a score of 21 on the MMSE might raise concern in a highly educated 60-year-old but could be considered normal variation in a 78-year-old with a high school education.
Ask your doctor: “Does this score indicate cognitive decline compared to what would be expected for someone my age and background?” and “Could my score be affected by other factors like depression, medication, or sleep deprivation?” Many screening results are influenced by temporary conditions that have nothing to do with dementia. A patient who is anxious during the test, struggling with untreated hypothyroidism, or taking medications that cloud thinking may perform worse than their actual cognitive capacity allows. Understanding whether your results reflect genuine decline or other correctable issues is essential before pursuing further expensive and sometimes invasive testing.
What Are the Limitations of This Screening Test?
It’s critical to understand that screening tests are not diagnostic tools—they’re designed to identify people who warrant further evaluation. A positive screening doesn’t mean you have dementia, and sometimes a negative screening can miss early cognitive problems, particularly in highly educated people whose intellectual reserve masks decline that would show up on more formal testing. Ask your doctor directly: “What are the false positive and false negative rates for this particular test?” and “Are there circumstances where this test might give misleading results?” One major limitation many people don’t realize is that screening tests primarily detect moderate cognitive impairment and don’t reliably catch mild cognitive impairment—the stage between normal aging and dementia that many experts now view as critically important for early intervention.
Your screening may look normal, but you could still be in the earliest stages of cognitive decline that more comprehensive neuropsychological testing would identify. Conversely, if you performed poorly on a screening, your doctor should be clear about what questions this raises but also what additional testing would need to confirm. A single screening test is a red flag, not a diagnosis.
What Additional Testing or Evaluation Do You Recommend?
If your screening raises concerns, ask what diagnostic pathway your doctor recommends. Depending on the findings, this might include neuropsychological testing (a much more comprehensive 6-8 hour evaluation with a specialist), brain imaging like an MRI or PET scan, blood tests for biomarkers like phosphorylated tau or amyloid, or a referral to a neurologist or geriatrician. Be specific about the reasoning for each test your doctor suggests.
Some people benefit from blood tests for treatable causes of cognitive decline—vitamin b12 deficiency, thyroid disease, or depression—before assuming the problem is neurodegenerative. Ask: “Before we move to advanced imaging or neuropsychological testing, should we check for reversible causes of cognitive decline?” Understanding the step-by-step logic of your diagnostic pathway helps you prepare emotionally and financially. Neuropsychological testing can cost $1,500-$3,000 without insurance coverage, and imaging can add thousands more. You have a right to know which tests are truly necessary versus optional, and what each test will or won’t tell you.
If This Is Dementia, What Type and Stage Are We Looking At?
A dementia screening cannot tell you which type of dementia you might have—that requires more specialized testing and clinical judgment. Alzheimer’s disease accounts for 60-80% of dementia cases, but frontotemporal dementia, Lewy body dementia, vascular dementia, and other variants each have different progressions and treatment implications. Your doctor should be honest about what their initial impression is, while being clear that confirmation requires further evaluation.
Equally important is understanding the concept of cognitive staging. Ask: “If these findings do indicate dementia, how early in the disease process would you say we are?” Early-stage dementia presents very differently from middle or advanced stages, and knowing where you are on that spectrum affects everything from your ability to work and drive to which medications might help. Someone in early-stage dementia might have many years of relatively independent functioning ahead, while someone in middle stages faces more immediate challenges with daily activities and safety. This information should inform your conversations about planning, treatment goals, and lifestyle modifications.
What Treatment Options or Interventions Are Available?
Don’t assume that a cognitive screening finding automatically leads to medication. Ask your doctor: “Are there medications that might help, and what is the evidence for how much they help?” Current FDA-approved drugs like aducanumab, lecanemab, or donanemab have shown modest slowing of decline in early Alzheimer’s disease, but they work best when started very early, have potential risks, and cost tens of thousands of dollars. Some drugs work better for certain types of dementia than others. Beyond medication, your doctor should discuss non-pharmaceutical interventions with strong evidence: cognitive training, physical exercise, Mediterranean or MIND diet patterns, cognitive stimulation activities, and management of vascular risk factors like blood pressure and cholesterol.
Research shows that someone with mild cognitive impairment who exercises regularly and engages in cognitively stimulating activities may slow decline more effectively than medication alone. Ask which interventions your doctor thinks would be most beneficial for your specific situation, and what the realistic expectations are. A warning: be cautious of aggressive memory-training programs or supplements that claim dramatic improvements. The evidence for most memory supplements is weak, and spending thousands on unproven interventions can prevent people from trying interventions with stronger evidence.
What Should My Family Know, and What Planning Should We Start Now?
Ask your doctor: “What should I tell my family about these results, and what conversations should we have?” If cognitive decline is confirmed, your family should understand what to expect, how to support you, and what legal and financial planning becomes important. This might include updating a power of attorney, discussing driving safety, or planning for long-term care. Your doctor can also advise whether genetic testing or family screening makes sense.
Some forms of early-onset dementia run in families with clear genetic patterns, while late-onset Alzheimer’s has genetic risk factors (like APOE4) that are increasingly available to test for. Understanding whether your family members should be concerned or screened can influence their own health decisions. Ask specifically: “Should my adult children be concerned about their own risk, and is there anything they should do now to reduce their risk?”.
How Often Should I Be Monitored, and What Should I Watch For?
Ask your doctor about a follow-up plan. If your screening was normal but you’re worried about decline, how often should you be retested? If findings are concerning, what’s the timeline for additional testing and follow-up appointments? Cognitive decline can be subtle, and establishing a baseline and regular monitoring helps distinguish true decline from normal variation. Your doctor should also help you identify warning signs to watch for between visits.
These might include getting lost in familiar places, difficulty managing finances or medications, increased frustration or behavioral changes, or challenges with complex tasks like cooking or home repairs. Knowing what to watch for empowers you and your family to notice changes early, when more interventions become possible. Ask: “What changes in my day-to-day functioning should I report to you immediately?” and “Should I keep a log of any cognitive or behavioral changes?”.
Conclusion
A dementia screening is a starting point for understanding your cognitive health, not a final answer. The questions you ask in the appointment following your screening can dramatically affect the quality of information you receive, the accuracy of diagnosis, and your ability to make informed decisions about your care.
Don’t leave your doctor’s office without understanding your actual scores, the limitations of the screening, what additional testing is planned and why, what realistic expectations are for diagnosis and treatment, and what your monitoring and follow-up looks like. Remember that you are not just a patient with test scores—you’re a person with a full life, concerns, and the right to understand your health situation clearly. A good doctor welcomes these questions and takes the time to ensure you fully understand what comes next.
Frequently Asked Questions
What’s the difference between a dementia screening and a dementia diagnosis?
A screening is a brief test that identifies whether further evaluation is needed. A diagnosis requires more comprehensive testing, medical history, imaging, and clinical evaluation from a specialist.
If my screening is normal, does that mean I definitely don’t have dementia?
Not entirely. Screening tests can miss mild cognitive impairment or early dementia, especially in highly educated people. If you have ongoing concerns, ask your doctor about more comprehensive neuropsychological testing.
Can I refuse additional testing after an abnormal screening?
Yes, you can refuse any medical test. However, you should understand what that decision means for diagnosis and treatment. Have that conversation with your doctor.
How long does it take to get a dementia diagnosis after an abnormal screening?
This varies widely. If additional testing is needed, it can take weeks to months. Neuropsychological testing can take 2-4 weeks to schedule. Brain imaging may be done within days.
What should I bring to my follow-up appointment after screening?
Bring a list of all medications and supplements, any previous cognitive or psychological testing results, a family member who can provide corroborating information about your functioning, and a list of your questions.
Can dementia be prevented if I have early warning signs?
While dementia cannot be prevented with certainty, people with mild cognitive impairment who exercise regularly, stay cognitively active, manage cardiovascular risk factors, and maintain strong social connections show slower decline than those who don’t. Early intervention is valuable.
You Might Also Like
- What Happens During a Dementia Evaluation?
- What Factors Affect Dementia Life Expectancy?
- What Affects Vascular Dementia Prognosis?
For more, see Alzheimer’s Association — medical tests.
